Sustained Benefits With TransCon PTH in Hypoparathyroidism

TOPLINE: Long-term treatment with TransCon parathyroid hormone (PTH), a replacement therapy for hypoparathyroidism, demonstrates sustained efficacy and safety in patients with hypoparathyroidism over 52 weeks, with 95% of participants able to discontinue conventional therapy. METHODOLOGY: Conventional therapy for hypoparathyroidism (active vitamin D and elemental calcium) alleviates symptoms of hypocalcemia, butContinue Reading

High-speed 3D bioprinter can fabricate structures that closely mimic diverse tissues in human body

The 3D bioprinter at the Collins BioMicrosystems Laboratory at the University of Melbourne. Credit: University of Melbourne Biomedical engineers from the University of Melbourne have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissueContinue Reading